MY102124A - Pharmaceutical composition for use against hypertension and congestive heart failure - Google Patents

Pharmaceutical composition for use against hypertension and congestive heart failure

Info

Publication number
MY102124A
MY102124A MYPI87003005A MYPI19873005A MY102124A MY 102124 A MY102124 A MY 102124A MY PI87003005 A MYPI87003005 A MY PI87003005A MY PI19873005 A MYPI19873005 A MY PI19873005A MY 102124 A MY102124 A MY 102124A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical composition
heart failure
congestive heart
use against
against hypertension
Prior art date
Application number
MYPI87003005A
Other languages
English (en)
Inventor
Helene Siegl Dr
Robert Paul Hof Dr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY102124A publication Critical patent/MY102124A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI87003005A 1986-11-03 1987-11-02 Pharmaceutical composition for use against hypertension and congestive heart failure MY102124A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MY102124A true MY102124A (en) 1992-03-31

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87003005A MY102124A (en) 1986-11-03 1987-11-02 Pharmaceutical composition for use against hypertension and congestive heart failure

Country Status (25)

Country Link
KR (1) KR960005145B1 (de)
AT (1) AT397343B (de)
AU (1) AU615883B2 (de)
BE (1) BE1002063A4 (de)
CA (1) CA1314222C (de)
CH (1) CH677189A5 (de)
DE (1) DE3736505A1 (de)
DK (1) DK574087A (de)
ES (1) ES2010524A6 (de)
FI (1) FI874823A (de)
FR (1) FR2605885B1 (de)
GR (1) GR871680B (de)
HK (1) HK138893A (de)
HU (1) HU199681B (de)
IE (1) IE60496B1 (de)
IL (1) IL84343A (de)
IT (1) IT1212037B (de)
LU (1) LU87034A1 (de)
MY (1) MY102124A (de)
NL (1) NL8702502A (de)
NO (1) NO874539L (de)
NZ (1) NZ222401A (de)
PH (1) PH23249A (de)
PT (1) PT86062B (de)
SE (1) SE8704272L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (es) 1989-11-16
IL84343A (en) 1993-07-08
KR960005145B1 (ko) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (de) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (sv) 1987-11-02
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
LU87034A1 (fr) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
SG52709A1 (en) Substituted imidazoles
MY110205A (en) Imidazolyl-alkenoic acids.
WO1996028185A3 (en) Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
IL74147A0 (en) Substituted hexahydro-aryl-quinolizines and salts thereof and pharmaceutical compositions containing them
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
MY102124A (en) Pharmaceutical composition for use against hypertension and congestive heart failure
AU574978B2 (en) Method for treatment of antidiuresis employing serine derivatives
GR862285B (en) Pharmaceutical compositions for treating the high blood pressure
AR243159A1 (es) Procedimiento de preparacion de acido 1-(3-mercapto-(2s)-metilpropionil)-pirrolidin-(2s)-carboxilico o sus sales farmaceuticamente aceptables.
DE3480325D1 (en) Pharmaceutical dosage unit
GB8823283D0 (en) Pharmaceutical composition for use against hypertension & congestive heart failure
GB9014705D0 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
MX9710002A (es) Nuevo uso medico.
GB9016701D0 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
IT8619931A1 (it) Procedimento per la preparazione della 1-(N-metilamidino)-3-{2,6-dimetilfenil)urea e dei suoi sali farmaceuticamente accettabili